GEIST:UPC Searchengine

ORD_61355/2024

DexCom, Inc.

Datum
2024-11-20
Kammer
Düsseldorf (DE) Local Division
Verfahrensart
Generic application
Sprache
EN

Metadaten

Fall-IDORD_61355-2024-e93895f75629
Aktenzeichen
RegisterzeichenORD_61355/2024
EntscheidungsreferenzORD_61355/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 3

1 Düsseldorf Local Division UPC_CFI_499/2023 Procedural Order of the Court of First Instance of the Unified Patent Court issued on 20 November 2024 concerning EP 4 026 488 CLAIMANT: DexCom, Inc., 6340 Sequen ce Drive, San Diego, California 92121, USA, represented by its CEO Kevin Sayer, represented by: Dr. Markus Grosch, Dr. Johannes Bukow, Dr. Jan Axtmann, Paul Lehmann, Quinn Emanuel Urquhart & Sullivan LLP, Moll- straße 42, 68165 Mannheim, Germany, electronic address for service: marcusgrosch@quinnemanuel.com DEFENDANTS: 1. Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064 -6400, USA, repre- sented by its board of directors which is represented by the CEO Robert Ford, 2. Abbott Diabetes Care Inc., 1360 South Loop Road, Ala-meda, California 94502, USA, repre- sented b ...